IP Library › Granted Patent US 7,534,786
Granted Patent B2
US 7,534,786 · App. 11/979,252 · Granted May 19, 2009

Inhibition of tau-tau association

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,534,786
App. No.
11/979,252
Granted
May 19, 2009
Kind
B2
Abstract

The present invention relates to methods for the detection of substances capable of modulating or inhibiting pathological tau-tau protein association. The methods of the present invention are particularly useful in screening substances for the prophylaxis and treatment of Alzheimer's disease.

Claims (4)

1. A method for the treatment of Alzheimer's disease, which method comprises administering to a subject in need thereof an effective amount of Methylene Blue, wherein the Methylene Blue is administered orally in a daily dosage of about 50 mg to about 700 mg.

2. A method according to claim 1 wherein the Methylene Blue is administered orally in a daily dosage of about 150 mg to about 300 mg.

3. A method according to claim 1 wherein the dosage is divided into 1 to 3 unit doses.

4. A method according to claim 1 wherein the unit doses are of the same amount.

Assignments (1)
CHANGE OF ADDRESS Recorded Jan 20, 2015
From: WISTA LABORATORIES LTD.
To: WISTA LABORATORIES LTD.
Reel/Frame 034781/0897 →